Smoking is becoming increasingly concentrated in people with co-factor
s such as depression, attention deficit-hyperactivity disorder, anxiet
y disorders, and bulimia/bingeing. These behavioral or cognitive patte
rns may be adaptive or neutral in the conditions under which we evolve
d but maladaptive in environments requiring alertness for extended per
iods, where a fully mobilized fight-or-flight response is inappropriat
e, and where food availability makes lack of an ''appestat'' a liabili
ty. Such conditions are amenable to management by nicotine because of
its ability to produce small but reliable adjustments in relevant cogn
itive and behavioral functions. Moreover, symptomatology may be unmask
ed or exacerbated by nicotine abstinence, persisting beyond the usual
time-course for nicotine withdrawal, which may explain the particular
attraction of smoking and the difficulty these individuals experience
in quitting without necessarily requiring that they be more nicotine-d
ependent. The implications are: (1) a better understanding of the evol
utionary psychobiology of smoking may promote development of tailored
interventions for smokers with co-factors; (2) nicotine may have thera
peutic applications for non-smokers with co-factors; (3) because smoki
ng has a fairly high heritability index, and because of evidence of as
sortative mating, special prevention efforts targeting children of smo
kers with co-factors, as well as early identification of the co-factor
itself, may be needed.